Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).
Gut transit time varies from one person to the next. Recent estimates suggest it can take somewhere between 12 and 73 hours ...